KLRS
Kalaris Therapeutics

88
Mkt Cap
$94.07M
Volume
49,360.00
52W High
$24.15
52W Low
$2.14
PE Ratio
-0.66
KLRS Fundamentals
Price
$5.03
Prev Close
$4.74
Open
$4.76
50D MA
$4.80
Beta
1.21
Avg. Volume
727,297.57
EPS (Annual)
-$11.73
P/B
1.77
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
News Placeholder
Kalaris Therapeutics Inc. (KLRS) Upgraded to Buy: Here's What You Should Know
Kalaris Therapeutics Inc. (KLRS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·2mo ago

Latest KLRS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.